Company MustGrow Biologics Corp. Canadian Securities Exchange
Equities
MGRO
CA62822A1030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | +6.74% | -28.57% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Natural Biopesticide
100.0
%
| 0 | 100.0 % | 5 | 100.0 % | +72,630.36% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
86.4
%
| - | - | 4 | 86.4 % | - |
Japan
13.6
%
| - | - | 1 | 13.6 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Corey Giasson
CEO | Chief Executive Officer | 46 | 18-03-14 |
Todd Lahti
DFI | Director of Finance/CFO | 58 | 18-12-16 |
Colin Bletsky
COO | Chief Operating Officer | 49 | 18-03-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Brad Munro
CHM | Chairman | 64 | 18-03-14 |
Corey Giasson
CEO | Chief Executive Officer | 46 | 18-03-14 |
Thomas Flow
BRD | Director/Board Member | 47 | 18-05-30 |
Colin Bletsky
COO | Chief Operating Officer | 49 | 18-03-14 |
Matt Kowalski
BRD | Director/Board Member | - | 18-05-30 |
Laura Westby
BRD | Director/Board Member | - | 22-03-14 |
David Borecky
BRD | Director/Board Member | - | 20-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,463,575 | 44,305,978 ( 86.09 %) | 0 | 86.09 % |
Company contact information
MustGrow Biologics Corp.
201 1st Avenue South Suite 1005
S7K 1J5, Saskatoon
+306-668-2652
http://www.mustgrow.caSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- MGRO Stock
- MGRO Stock
- Company MustGrow Biologics Corp.